Seeking Alpha

huskers123

huskers123
Send Message
View as an RSS Feed
View huskers123's Comments BY TICKER:
Latest  |  Highest rated
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    Your broker won't let you short OTC stocks. Give me a break Mako.
    Sep 4, 2015. 08:52 PM | Likes Like |Link to Comment
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    Obviously he has been always short, maybe he is a shark we all know about that wrote a recent article. You can't be a DR. and read Mako's article and say it somehow enlighten you. If he was a Dr. he'd know that there were so many holes in that article. I still haven't found anything in it that had any merit.
    Sep 4, 2015. 08:46 PM | Likes Like |Link to Comment
  • A Professional Fight :The Shorts Vs Cellceutix [View instapost]
    They seem to get others to pay most of the costs of the trials,like Dana Faber. With Purisol that's not the Case. Good take on the fighter analogy. CTIX got hit with a left hooked,but will Counter with 5 trials, B-OM, B Phase III,Kevetrin, Kevtrin combo, Purisol...all above the belt. LOL.
    Aug 20, 2015. 09:50 PM | Likes Like |Link to Comment
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    We traded over 1.1 million shares today...perhaps capitulation.
    Aug 19, 2015. 04:44 PM | 1 Like Like |Link to Comment
  • Cellceutix: Empty Office, Unviable 'Science', Misleading Disclosures, 96% Downside [View article]
    Hanging on to that administrative error. Nothing else in your article has been shown to be true. Has it now Mako or Dr Ten Bagger are you one in the same?
    Aug 18, 2015. 05:15 PM | 1 Like Like |Link to Comment
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    Matija, I'd be interested after the 11 Cohort data is released and your assessment. Also what would be the potential of the drug for OC. Thanks!
    Aug 17, 2015. 01:41 PM | 1 Like Like |Link to Comment
  • Cellceutix: Empty Office, Unviable 'Science', Misleading Disclosures, 96% Downside [View article]
    They approve the design of the trial. A Company can move forward without the FDA's input no the trial design, but that usually doesn't end up to well.
    Aug 17, 2015. 09:08 AM | 1 Like Like |Link to Comment
  • $CTIX - My Visit To Cellceutix, The Biotech That A Short Seller Recently Called A Sham [View instapost]
    Hi Karin. Short and Sweat, but further concludes on the slanderous SA article with nothing that I could find was true after all the rebuttals. It's dis-hearting that people will go to no length to make $, no matter how unethical. I hope for the best for CTIX and success, mainly for the potential of their drugs and how they can help people with serious heath diseases, $$$'s come second.

    I do believe CTIX is getting far enough along with the progress of the pipeline, that these type of "Hit" articles will be in the past.
    Aug 15, 2015. 06:29 PM | 2 Likes Like |Link to Comment
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    There actually is an SA article in 2013 or 2012 that had CTIX at $100 if their pipeline came in successfully.
    Aug 15, 2015. 06:06 PM | 2 Likes Like |Link to Comment
  • Cellceutix: Empty Office, Unviable 'Science', Misleading Disclosures, 96% Downside [View article]
    UNEMON1, your a little behind on the discussion.
    Aug 15, 2015. 06:02 PM | 1 Like Like |Link to Comment
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    A lot of so called un-biased or so called longs posting here that seem to be sheep in wolves clothing. With all the concerns they mentioned, one could surmise they are short and now questioning their own short thesis, like "oh-no everything I thought was true has now been de-bunked". Wouldn't surprise me if one of them is yes Mako, the anonymous one.
    Aug 13, 2015. 08:59 AM | 1 Like Like |Link to Comment
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    KarinCA, I agree with your points. I do agree with Slava22 on many other biotech's, just completely disagree with him on CTIX.
    Aug 12, 2015. 04:17 PM | 3 Likes Like |Link to Comment
  • Cellceutix: Small Biotech With High Risk / High Reward Profile [View article]
    Always enjoy your articles because they usually are spot on and balanced. I would say at the current stock price (thanks to Mako) a lot of the risk has been de-risked.

    CTIX's pipeline with multiple shots on goals, also further mitigates the risk.

    Thanks for writing the article!
    Aug 12, 2015. 11:58 AM | 5 Likes Like |Link to Comment
  • Cellceutix: Empty Office, Unviable 'Science', Misleading Disclosures, 96% Downside [View article]
    This is what was said. It doesn't sound to me like it was purposeful; otherwise, no correction would have been made. You are right the SEC and NY AG have both been notified.

    "There was an administrative error stating that Dr. Menon earned his PhD from Harvard, when the fact is that Dr. Menon worked as a research scientist at Dana-Farber Cancer Institute. This error was corrected years ago. The article that was published by India New England years ago was simply absurd and was removed by the publisher with all its links as an admission that the story was false."
    Aug 11, 2015. 04:50 PM | 3 Likes Like |Link to Comment
  • Cellceutix: Empty Office, Unviable 'Science', Misleading Disclosures, 96% Downside [View article]
    I read an article from the CEO of PCYC when it was in the hundreds...that was a pump job. I don't think aspiring to be like a REGN is pump. Responding to this article that is nothing more than accusations, all thoroughly debunked is not pumping.
    Aug 11, 2015. 08:40 AM | 2 Likes Like |Link to Comment
COMMENTS STATS
91 Comments
213 Likes